Fingolimod Rebound: A Review of the Clinical Experience and Management Considerations

Because the treatment of multiple sclerosis (MS) may span decades, the need often arises to make changes to the treatment plan in order to accommodate changing circumstances. Switching drugs, or the discontinuation of immunomodulatory agents altogether, may leave patients vulnerable to relapse or di...

Descripción completa

Detalles Bibliográficos
Autores principales: Barry, Brian, Erwin, April A., Stevens, Jessica, Tornatore, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858914/
https://www.ncbi.nlm.nih.gov/pubmed/31677060
http://dx.doi.org/10.1007/s40120-019-00160-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858914/
https://www.ncbi.nlm.nih.gov/pubmed/31677060
http://dx.doi.org/10.1007/s40120-019-00160-9

Ejemplares similares